|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2290-2299.
Prepublished online as a Blood First Edition Paper on June 27, 2006June 22, 2006; DOI 10.1182/blood-2006-03-010348.
Previous Article | Next Article 
Submitted March 15, 2006
Accepted May 24, 2006
Granzyme B, a novel mediator of allergic inflammation:
Its induction and release in blood basophils and human asthma
Cornelia M Tschopp, Nicole Spiegl, Svetlana Didichenko, Werner Lutmann, Peter Julius, J C Virchow, C E Hack, and Clemens A Dahinden*
Institute of Immunology, Inselspital, University of Bern, Switzerland
Department of Pneumology, University Medical Clinic, Rostock, Germany
Sanquin Research at the CLB, Amsterdam, the Netherlands
University Hospital
* Corresponding author; email: clemens.dahinden{at}iib.unibe.ch.
Histamine, leukotriene-C4, IL-4 and IL-13 are major mediators of allergy and asthma. They are all formed by basophils and are released in particularly large quantities after stimulation with IL-3. Here we show that supernatants of activated mast cells or IL-3 qualitatively change the make-up of granules of human basophils by inducing de-novo synthesis of granzyme B (GzmB), without induction of other granule proteins expressed by cytotoxic lymphocytes (granzyme A, perforin). This bioactivity of IL-3 is not shared by other cytokines known to regulate the function of basophils or lymphocytes. The IL-3 effect is restricted to basophil granulocytes as no constitutive or inducible expression of GzmB is detected in eosinophils or neutrophils. GzmB is induced within 6-24 hours, sorted into the granule compartment, and released by exocytosis upon IgE-dependent and - independent activation. In vitro, there is a close parallelism between GzmB, IL 13 and leukotriene-C4 production. In vivo, Granzyme B, but not the lymphoid granule marker granzyme A, is released 18 hours after allergen challenge of asthmatic patients in strong correlation with interleukin-13. Our study demonstrates an unexpected plasticity of the granule composition of mature basophils and suggests a role of granzyme B as a novel mediator of allergic diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Pieri, C. Bogani, P. Guglielmelli, M. Zingariello, R. A. Rana, N. Bartalucci, A. Bosi, and A. M. Vannucchi
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera
Haematologica,
November 1, 2009;
94(11):
1537 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Kroeger, B. M. Sullivan, and R. M. Locksley
IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38{alpha}-dependent pathway
J. Leukoc. Biol.,
October 1, 2009;
86(4):
769 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Ngan, S. V. Vickerman, D. J. Granville, S. F. P. Man, and D. D. Sin
The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease
Therapeutic Advances in Respiratory Disease,
June 1, 2009;
3(3):
113 - 129.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pecaric-Petkovic, S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Blood,
February 12, 2009;
113(7):
1526 - 1534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Didichenko, N. Spiegl, T. Brunner, and C. A. Dahinden
IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils
Blood,
November 15, 2008;
112(10):
3949 - 3958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Bratke, A Klug, P Julius, M Kuepper, M Lommatzsch, G Sparmann, W Luttmann, and J C Virchow
Granzyme K: a novel mediator in acute airway inflammation
Thorax,
November 1, 2008;
63(11):
1006 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Spiegl, S. Didichenko, P. McCaffery, H. Langen, and C. A. Dahinden
Human basophils activated by mast cell-derived IL-3 express retinaldehyde dehydrogenase-II and produce the immunoregulatory mediator retinoic acid
Blood,
November 1, 2008;
112(9):
3762 - 3771.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|